These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 359396)

  • 1. Intracellular pancreatic B cell serotonin and the dynamics of insulin release.
    Pulido OM; Bencosme SA; de Bold ML; de Bold AJ
    Diabetologia; 1978 Sep; 15(3):197-204. PubMed ID: 359396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin, of its biosynthetic precursors and of the anti-serotonin agent metergoline on the release of glucagon and insulin from rat pancreas.
    Pontiroli AE; Micossi P; Foá PP
    Horm Metab Res; 1978 May; 10(3):200-3. PubMed ID: 352887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase.
    Lindström P; Sehlin J
    Endocrinology; 1983 Apr; 112(4):1524-9. PubMed ID: 6339207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
    Feldman JM; Chapman B
    Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of 5-hydroxytryptamine for insulin secretion in the mouse.
    Lernmark A
    Horm Metab Res; 1971 Sep; 3(5):305-9. PubMed ID: 4944450
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.
    Verspohl EJ; Händel M; Hagenloh I; Ammon HP
    Acta Diabetol Lat; 1982; 19(4):303-17. PubMed ID: 6758458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
    Lundquist I; Ekholm R; Ericson LE
    Diabetologia; 1971 Dec; 7(6):414-22. PubMed ID: 5004176
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between 5-hydroxytryptamine release and insulin secretion.
    Gylfe E
    J Endocrinol; 1978 Aug; 78(2):239-48. PubMed ID: 359742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of mouse islet function by 5-hydroxytryptamine, dopamine and their precursors.
    Lindstöm P
    Acta Biol Med Ger; 1982; 41(12):1185-90. PubMed ID: 6765161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):251-64. PubMed ID: 241943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for calcium ion in insulin secretion by the perfused rat pancreas.
    Curry DL; Bennett LL; Grodsky GM
    Am J Physiol; 1968 Jan; 214(1):174-8. PubMed ID: 4863806
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of 5-hydroxytryptophan potentiation of glucose-induced insulin release.
    Lindström P
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):248-53. PubMed ID: 6375231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of adenosine triphosphate (ATP) on the secretion of insulin induced by tolbutamide in the absence of glucose].
    Chapal J; Roye M; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1980; 173(6):1120-3. PubMed ID: 6446366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of 5-hydroxytryptophan and 5-hydroxytryptamine on the function of microdissected ob/ob-mouse pancreatic islets.
    Lindström P; Sehlin J
    Diabetologia; 1983 Jan; 24(1):52-7. PubMed ID: 6337907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin components released by the normal and subtotal degranulated perifused islets of Langerhans of the rat.
    Hermida OG; Gómez-Acebo J
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):524-30. PubMed ID: 1091120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of linogliride on hormone release from perfused rat pancreas. Fuel dependence and desensitization by tolbutamide.
    Ronner P; Cheong E; Khalid P; Tuman RW; Matschinsky FM
    Diabetes; 1991 Jul; 40(7):878-84. PubMed ID: 2060724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.